Obesity Trial, Recruiting NCT06030362 Sponsor: University of California, Los Angeles Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06030362
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 50 years old
  • People with a body mass index (BMI) between 25 and 40 (a measure of body weight relative to height)
  • Both men and women are eligible
  • People who are not currently pregnant or breastfeeding

Who may not be able to join:

  • People with Type 1 (insulin-dependent) diabetes
  • People with vascular (blood vessel) disease
  • People who have lost more than 10 pounds in the past 2 months
  • People who exercise very heavily and frequently, such as marathon runners or heavy weightlifters
  • People who have had abdominal surgery, including weight loss surgery or removal of part or all of the stomach or bowel
  • People with untreated thyroid disease
  • People with a neurological (brain or nerve) disease
  • People with a serious medical condition that the trial doctor believes could put them at risk or affect the study results
  • People with chronic (long-term) pain
  • People with an active psychiatric illness (including eating disorders) as defined by the DSM IV — the condition must not have been present for at least 2 years; people who screen positive on a specific psychiatric assessment tool (called the MINI+) will not be eligible
  • People currently taking medications known to affect hunger or appetite
  • People who are pregnant, breastfeeding, or less than 6 months postpartum
  • Women who are able to become pregnant but are not using birth control, or who plan to become pregnant during the study
  • People who have used oral or intravenous (IV) antibiotics in the last 3 months
  • People who have used probiotic supplements in the last 3 months
  • People with heavy alcohol or drug use, as identified by a positive result on the MINI+ assessment; people who smoke more than half a pack of cigarettes per day
  • People who test positive on the MINI+ for drug dependence or abuse (cannabis use alone is not automatically exclusionary)
  • People who have made significant changes to their usual diet or lost more than 10 pounds in the last 2 months
  • People taking any medication included on the trial's specific medication exclusion list (confirm with trial site for the full list)
  • People who are not fluent in English, as the study uses validated questionnaires that are currently only available in English
  • People whose body weight at enrolment is greater than 400 pounds
  • For the optional MRI portion of the study only: people who cannot safely have an MRI, such as those with claustrophobia or certain medical devices like pacemakers, neurostimulators, or metallic implants

Note: People on long-term maintenance medications may still be eligible, provided the dose has been stable for at least 6 months (confirm with trial site).


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arpana Gupta, PhD, The Regents of the University of California, Los Angeles

Phone: 3108257206

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 July 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Differences in metabolite concentrations pre & post intervention - Stool; Differences in metabolite concentrations pre & post intervention - Blood; Differences in microbiome levels pre & post intervention - Stool; Differences in microbiome levels pre & post intervention - Blood; Differences in microbiome levels pre & post intervention - Stool; Differences in microbiome levels pre & post intervention - Blood

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov